Quality
Jason J. Luke, MD, FACP
Director and Associate Professor
Cancer Immunotherapeutics Center, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA
Pittsburgh, Pennsylvania, United States
Jason J. Luke, MD, FACP
Director and Associate Professor
Cancer Immunotherapeutics Center, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA
Pittsburgh, Pennsylvania, United States
Jason J. Luke, MD, FACP
Director and Associate Professor
Cancer Immunotherapeutics Center, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA
Pittsburgh, Pennsylvania, United States
Georgina V. Long, BSc PhD MB BS FRACP FAHMS
Director
Melanoma Institute Australia, The University of Sydney, Royal North Shore Hospital, and Mater Hospital, Sydney, NSW, Australia, United States
Caroline Robert, MD, PhD
Head of Dermatology Unit
Gustave Roussy and Paris-Saclay University, Villejuif-Paris, France, United States
Matteo S. Carlino, BMedSc MBBS FRACP PhD
Clinical Senior Lecturer Medicine
Melanoma Institute Australia, The University of Sydney, Westmead and Blacktown Hospitals, Sydney, NSW, Australia, United States
Toni K. Choueiri, MD
Director of the Lank Center for Genitourinary (GU) Oncology
Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA, United States
Naomi B. Haas, MD
Director, Prostate and Kidney Cancer Program
Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA, United States
Mary O'Brien, PhD
Medical Oncologist, Professor
Royal Marsden Hospital and Imperial College, London, United Kingdom, United States
Luis Paz-Ares, MD, PhD
Head of the H12O-CNIO Lung Cancer Clinical Research Unit
Complutense University, Cancer Network Biomedical Research Center Consortium (CIBERONC), Spanish National Cancer Research Center (CNIO) and University Hospital October 12, Madrid, Spain, United States
Solange Peters, MD, PhD
Professor
Vaud University Hospital Center (CHUV) and University of Lausanne, Lausanne, Switzerland, United States
Thomas Powles, MBBS, MRCP, MD
Director of Barts Cancer Centre and Professor
St Bartholomew's Hospital, West Smithfield, London, United Kingdom, United States
Melanie A. Leiby, PhD
Senior Director, Oncology Publications
Merck & Co., Inc., Rahway, NJ, USA, United States
Jianxin Lin, PhD
Senior Scientist
Merck & Co., Inc., Rahway, NJ, USA, United States
Yujie Zhao, MD, PhD
Senior Scientist
Merck & Co., Inc., Rahway, NJ, USA, United States
Clemens Krepler, MD
Executive Director
Merck & Co., Inc., Rahway, NJ, USA, United States
Rodolfo Perini, PhD
Senior Principal Scientist
Merck & Co., Inc., Rahway, NJ, USA, United States
M. Catherine Pietanza, MD
Global Director of Scientific Affairs for Oncology
Merck & Co., Inc., Rahway, NJ, USA, United States
Ayman Samkari, MD
Executive Director, Distinguished Scientist
Merck & Co., Inc., Rahway, NJ, USA, United States
Todd Gruber, PhD
Associate Vice President
Merck & Co., Inc., Rahway, NJ, USA, United States
Nageatte Ibrahim, MD
Vice president, Clinical Research
Merck & Co., Inc., Rahway, NJ, USA, United States
Alexander M. M. Eggermont, MD, PhD
Chief Scientific Officer, Board of Directors
University Medical Center Utrecht, Netherlands & Comprehensive Cancer Center Munich, Germany, United States